Phase II randomised clinical trial of personalized peptide vaccination in combination with Dai-kenchu-to for colorectal cancer patients resistant to standard therapies.
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
At a glance
- Drugs TJ 100 (Primary) ; Colorectal cancer vaccine; Incomplete Freund's adjuvant
- Indications Colorectal cancer
- Focus Pharmacodynamics
- 14 Jun 2012 New trial record